Standout Papers

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant gli... 2000 2026 2008 2017 779
  1. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial (2000)
    James M. Markert, Michael D. Medlock et al. Gene Therapy
  2. Oncolytic virus therapy: A new era of cancer treatment at dawn (2016)
    Hiroshi Fukuhara, Yasushi Ino et al. Cancer Science
  3. Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial (2022)
    Tomoki Todo, Hirotaka Ito et al. Nature Medicine
  4. A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma (2022)
    Tomoki Todo, Yasushi Ino et al. Nature Communications

Immediate Impact

6 by Nobel laureates 27 from Science/Nature 62 standout
Sub-graph 1 of 20

Citing Papers

Glioblastoma and Other Primary Brain Malignancies in Adults
2023 Standout
CAR T therapy beyond cancer: the evolution of a living drug
2023 StandoutNature
5 intermediate papers

Works of Tomoki Todo being referenced

Oncolytic virus therapy: A new era of cancer treatment at dawn
2016 Standout
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
2001
and 5 more

Author Peers

Author Last Decade Papers Cites
Tomoki Todo 3055 3273 1744 2757 141 7.0k
James M. Markert 3121 4328 2247 3387 194 8.3k
E. Antonio Chiocca 2060 1973 777 1205 80 4.6k
Samuel D. Rabkin 5254 7098 3335 4758 168 10.7k
Cheryl A. Palmer 1465 1495 1065 1149 105 4.4k
Elio F. Vanin 4660 2251 390 2059 92 7.2k
C. Ryan Miller 3303 1611 298 2020 152 6.2k
Khalid Shah 4599 1296 451 2151 134 8.2k
Clive Dickson 8997 3198 547 3353 148 12.7k
Robert L. Martuza 4876 5969 5290 4609 173 13.1k
David A. Largaespada 7666 2593 507 1842 212 11.6k

All Works

Loading papers...

Rankless by CCL
2026